Latest news
PCI Biotech to present at IPA World Congress
Oslo, Norway, July 1, 2019 PCI Biotech (OSE:PCIB), a clinical-stage company developing innovative therapeutics that address significant unmet medical needs, today announced that it will present the company at the International Photodynamic Association (IPA) World Congress in Boston, US. PCI Biotech will be represented by Per Walday (CEO), Hans Olivecrona (CMO) and Anders Høgset (CSO) who […]
Employee share option scheme
Oslo, 21 June 2019 – In accordance with the authorisation granted by the Annual General Meeting 29 May 2019, the Board of Directors of PCI Biotech Holding ASA has awarded a total of 320,000 share options to key employees. Each share option gives the right to subscribe for or acquire one share per option (after PCI […]
Minutes from Annual General Meeting 2019
Oslo, 29 May 2019. The Annual General Meeting in PCI Biotech Holding ASA took place today, 29 May 2019. All proposals were resolved by the Annual General Meeting as presented in the notice convening the general meeting distributed on 8 May 2019. The Board of Directors consists of the following members until the next Annual […]